Your trusted source for investing success


Five Prime Therapeutics Announces Closing of Upsized Public Offering

Five Prime Therapeutics (Nasdaq:FPRX) announced today the closing of its upsized public offering of 5,897,435 shares of its common stock, which includes 769,230 shares sold upon the underwriters’ full exercise of their option to purchase additional shares, resulting in aggregate gross proceeds of $115 million, before deducting underwriting discounts and

Five Prime Announces Proposed Public Offering of Common Stock

Five Prime Therapeutics (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced today that it plans to offer and sell, subject to market and other conditions, $75,000,000 of shares of its common stock in an underwritten public offering.

As quoted in the press release:

Five Prime

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
India's Graphite Electrode Producers Under Pressure to Cut Prices